Visualizing inflammation activity in rheumatoid arthritis with Tc-99 m anti-CD4-mAb fragment scintigraphy.

[1]  T. Pincus,et al.  Radiographic measures to assess patients with rheumatoid arthritis: advantages and limitations. , 2009, Rheumatic diseases clinics of North America.

[2]  R. Dierckx,et al.  Molecular imaging of rheumatoid arthritis by radiolabelled monoclonal antibodies: new imaging strategies to guide molecular therapies , 2009, European Journal of Nuclear Medicine and Molecular Imaging.

[3]  N. Bansback,et al.  The economics of treatment in early rheumatoid arthritis. , 2009, Best practice & research. Clinical rheumatology.

[4]  A. Kavanaugh.  Economic consequences of established rheumatoid arthritis and its treatment. , 2007, Best practice & research. Clinical rheumatology.

[5]  W. Brenner.  18F-FDG PET in rheumatoid arthritis: there still is a long way to go. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[6]  F. Emmrich,et al.  Minimal contribution of cell-bound antibodies to the immunoscintigraphy of inflamed joints with 99mTc-anti-CD4 monoclonal antibodies , 2002, Nuklearmedizin.

[7]  F. Debruyne,et al.  In vivo and in vitro characterizations of three 99mTc-labeled monoclonal antibody G250 preparations. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[8]  F. Emmrich,et al.  Rat adjuvant arthritis: imaging with technetium-99m-anti-CD4 Fab' fragments. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[9]  M. Abrams,et al.  [99mTc]tricine: a useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates. , 1995, Bioconjugate chemistry.

[10]  F. Emmrich,et al.  Imaging rheumatoid arthritis joints with technetium-99m labelled specific anti-CD4− and non-specific monoclonal antibodies , 1994, European Journal of Nuclear Medicine.

[11]  F. Emmrich,et al.  Comparison of 99Tcm-labelled specific murine anti-CD4 monoclonal antibodies and nonspecific human immunoglobulin for imaging inflamed joints in rheumatoid arthritis. , 1993, Nuclear medicine communications.

[12]  F. Emmrich,et al.  Advances in immunotherapy of rheumatoid arthritis: clinical and immunological findings following treatment with anti-CD4 antibodies. , 1993, British Journal of Rheumatology.

[13]  Wendy S. Becker,et al.  Kinetics of 99mTc-Labelled Antibodies against CD4 (T-Helper) Lymphocytes in Man , 1992, Nuklearmedizin.

[14]  A. Fischman,et al.  Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. , 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[15]  F. Arnett.  Revised criteria for the classification of rheumatoid arthritis. , 1990, Orthopedic nursing.

[16]  M. Liang,et al.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. , 1988, Arthritis and rheumatism.

[17]  F. Emmrich,et al.  Imaging rheumatoid arthritis specifically with technetium 99m CD4-specific (T-helper lymphocytes) antibodies , 2004, European Journal of Nuclear Medicine.

[18]  F. Emmrich,et al.  In vivo stability and metabolism of 99Tcm-labelled anti-CD4 monoclonal antibodies and Fab' fragments. , 1999, Nuclear medicine communications.

[19]  F. Emmrich,et al.  Joint uptake and body distribution of a technetium-99m-labeled anti-rat-CD4 monoclonal antibody in rat adjuvant arthritis. , 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[20]  F. Emmrich,et al.  An anti-CD4 antibody for treatment of chronic inflammatory arthritis. , 1991, Agents and actions. Supplements.